Cephalexin-induced acute generalized exanthematous pustulosis

Matthew DaCunha; Sarah Moore; David Kaplan

doi:10.4081/dr.2018.7686

Cephalexin-induced acute generalized exanthematous pustulosis

https://doi.org/10.4081/dr.2018.7686

PDF HTML

Vol. 10 No. 2 (2018)

Submitted: 18 March 2018
Accepted: 19 July 2018

Published: 1 October 2018

Tender, Erythematous, Pustular eruption, Drug reaction, Antibiotic.

Abstract Views: 1070

PDF: 551
HTML: 76

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Matthew DaCunha University of Kansas Medical Center, Kansas City, Kansas, United States.
Sarah Moore University of Kansas Medical Center, Kansas City, Kansas, United States.
David Kaplan
dookdoc@gmail.com
University of Kansas Medical Center, Kansas City, Kansas, United States.

Cephalexin is a cephalosporin antibiotic that is commonly used in the treatment of infectious diseases. We report a patient exhibiting a rare adverse effect of cephalexin: drug-induced Acute Generalized Exanthematous Pustulosis (AGEP). We present this case because of the scarcity of reports associating cephalexin with AGEP in hopes that clinicians will consider AGEP in their differential diagnosis in the appropriate clinical setting.

Supporting Agencies

DaCunha, M., Moore, S., & Kaplan, D. (2018). Cephalexin-induced acute generalized exanthematous pustulosis. Dermatology Reports, 10(2). https://doi.org/10.4081/dr.2018.7686